HAVN Life Sciences Inc. (HAVLF)
HAVN Life Sciences Inc. is a biotechnology firm that specializes in the research and innovation of psychotropic compounds derived from botanical and fungal organisms. The company is also dedicated to establishing standardized, quality-controlled methodologies for extracting these psychoactive molecules, with a specific focus on Psilocybe mushroom species and their key constituents such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health products utilizing unregulated ingredients. Founded in 2020, HAVN Life Sciences' operations are headquartered in Richmond, Canada.
Sector: Biotechnology
Industry: Biotechnology
HAVN Life Sciences Inc.
- Not computed yet: no FINRA short interest has been matched to this float.
- 73
- 1.00
Float 23.10M · FMP free float
The cost to borrow HAVLF shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.
- No fails on record for 16–31 Oct 2026.
No price or settlement history available to chart.
FINRA publishes no off-exchange short volume for this symbol.
FINRA's weekly alternative trading system (dark pool) volume for HAVLF: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.